# ASTAGRAF XL
> **NDA204096** · New Drug Application · Sponsor: ASTELLAS · Approved 2013-07-19
## Drug
- **FDA Application Number:** NDA204096
- **Application type:** New Drug Application
- **Brand name:** ASTAGRAF XL
- **Generic name:** TACROLIMUS EXTENDED-RELEASE CAPSULES
- **Active ingredients:** TACROLIMUS
- **Dosage form:** CAPSULE, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** ASTELLAS
- **Manufacturer:** Astellas Pharma US, Inc.
- **First approval:** 2013-07-19
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204096)
---
*MORVS · CC0 1.0*